Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Valley National Bancorp Common Stock (VLY) Price & Performance

Iovance Biotherapeutics Inc. Common StockTrade
Valley National Bancorp Common StockTrade

Price performance (Past 24H)

Key statistics

Iovance Biotherapeutics Inc. Common Stock vs Valley National Bancorp Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.53 (market cap $6.04B), while Valley National Bancorp Common Stock trades at $12.64 (market cap $7.05B). The key difference: Valley National Bancorp Common Stock is the larger of the two by market cap, and Valley National Bancorp Common Stock pays a 3.45% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Valley National Bancorp Common Stock for 0 Days on average.

IOVAVLY
Market Cap
$6.04B$7.05B
Volume
14,805,9937,669,925
Sector
HealthFinancials
52-Week High
$14.82$15.19
52-Week Low
$1.81$9.72
Typical Hold Time
0 Days0 Days
Enterprise Value
$5.97B$9.55B
Dividend Yield
—3.45%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IOVA
100% Buy0% Sell
Avg holding period · 0 Days
VLY
100% Buy0% Sell
Avg holding period · 0 Days

About Iovance Biotherapeutics Inc. Common Stock

Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.

Read more on IOVA →

About Valley National Bancorp Common Stock

Valley National Bancorp is a financial holding company whose main subsidiary is Valley National Bank. It provides commercial, retail, trust, and investment services across several U.S. states.

Read more on VLY →